Clinical Trial

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Name: Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma — clinical trial record (NCT07441499)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Application of Multi-Component Liquid Biopsy (ctDNA, utDNA, Exosomes, and Protein Biomarkers in Blood and Urine) for Auxiliary Diagnosis, Therapeutic Response Evaluation, and Recurrence Monitoring in Urothelial Carcinoma

Trial Details

NCT Number	NCT07441499
Lead Sponsor	Tianjin Medical University Second Hospital
Conditions	Urothelial Carcinoma (UC), Bladder (Urothelial, Transitional Cell) Cancer, Liquid Biopsy
Enrollment	300 participants
Start Date	2026-03
Primary Completion	2027-01-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-02